ストックスクリーナーアプリを入手
1.28
2.29%
-0.03
前日終値:
$1.31
開ける：
$1.31
24時間の取引高:
920.71K
Relative Volume:
0.74
時価総額：
$128.46M
収益：
-
当期純損益:
$-20.31M
株価収益率:
-4.8393
EPS:
-0.2645
ネットキャッシュフロー:
$-21.07M
1週間 パフォーマンス:
+20.75%
1か月 パフォーマンス:
+48.79%
6か月 パフォーマンス:
+103.17%
1年 パフォーマンス:
+33.51%
1日の値動き範囲:
$1.25
$1.33
1週間の範囲:
$1.14
$1.44
52週間の値動き範囲:
$0.3258
$1.53
Oncolytics Biotech Inc Stock (ONCY) Company Profile
ONCY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ONCY
Oncolytics Biotech Inc
|
1.28 | 132.63M | 0 | -20.31M | -21.07M | -0.2645 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Oncolytics Biotech Inc Stock (ONCY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-13 | 開始されました | Lake Street | Buy |
| 2022-10-06 | 開始されました | Maxim Group | Buy |
| 2021-02-17 | 開始されました | H.C. Wainwright | Buy |
Oncolytics Biotech Inc (ONCY) 最新ニュース
Oncolytics Biotech (TSE:ONC) Shares Pass Above 200 Day Moving AverageTime to Sell? - MarketBeat
Will Oncolytics Biotech's (ONCY) Upcoming CEO Presentation Reinforce Management Credibility Among Investors? - simplywall.st
FDA Accelerates Cancer Drug Pipeline as Market Momentum Surges Past $400B - Baystreet.ca
Breakthrough Therapy Designations Surge as $50B Cancer Drug Partnerships Reshape Market - The Malaysian Reserve
Oncolytics Biotech® Highlights Strong Efficacy and Translational Data in Metastatic Colorectal Cancer; Will Advance Regulatory Pathway Discussions - Cantech Letter
Stocks In Play: Oncolytics Biotech Inc - Barchart.com
Premarket Movers: RAPP, MCRB, JAGX. MEIP… - RTTNews
Oncolytics Biotech Reports Promising Results in Metastatic Colorectal Cancer Studies - TipRanks
Is Oncolytics Biotech Inc. a speculative investmentNew Guidance & High Accuracy Swing Entry Alerts - خودرو بانک
What’s next for Oncolytics Biotech Inc. stockEarnings Recap Report & Stepwise Swing Trade Plans - خودرو بانک
What is Oncolytics Biotech Inc.’s TAM (Total Addressable Market)Weekly Investment Summary & Weekly High Return Forecasts - خودرو بانک
Multi asset correlation models including Oncolytics Biotech Inc.2025 Top Gainers & High Accuracy Buy Signal Tips - Newser
Will Oncolytics Biotech Inc. stock recover after recent dropBond Market & Fast Entry and Exit Trade Plans - Newser
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights - Quantisnow
Technical signs of recovery in Oncolytics Biotech Inc.2025 Macro Impact & Reliable Volume Spike Trade Alerts - Newser
Chart overlay techniques for tracking Oncolytics Biotech Inc.Trade Analysis Report & Low Drawdown Investment Strategies - Newser
Does Oncolytics Biotech Inc. meet Warren Buffett’s criteriaWeekly Market Summary & Daily Entry Point Trade Alerts - خودرو بانک
How to manage a losing position in Oncolytics Biotech Inc.Quarterly Portfolio Report & Real-Time Volume Analysis - Newser
Does Oncolytics Biotech Inc. show high probability of reboundEarnings Growth Report & Entry Point Strategy Guides - Newser
Leading vs lagging indicators on Oncolytics Biotech Inc. performance2025 Trade Ideas & AI Based Buy/Sell Signal Reports - Newser
How to forecast Oncolytics Biotech Inc. trends using time seriesQuarterly Earnings Report & Consistent Profit Trading Strategies - Newser
Can Oncolytics Biotech Inc. navigate macro headwindsWeekly Loss Report & Daily Risk Controlled Trade Plans - خودرو بانک
Can swing trading help recover from Oncolytics Biotech Inc. lossesMarket Volume Report & Safe Entry Point Alerts - Newser
Can Oncolytics Biotech Inc. reach all time highs this yearGlobal Markets & Momentum Based Trading Ideas - خودرو بانک
Is Oncolytics Biotech Inc. likely to announce a buybackAnalyst Downgrade & Safe Capital Growth Trade Ideas - خودرو بانک
Is Oncolytics Biotech Inc. still worth holding after the dip2025 Price Momentum & Reliable Volume Spike Trade Alerts - Newser
Oncolytics Biotech Inc. stock retracement – recovery analysisTrade Ideas & Verified Technical Signals - Newser
Applying big data sentiment scoring on Oncolytics Biotech Inc.Market Sentiment Summary & High Conviction Buy Zone Picks - Newser
Quantitative breakdown of Oncolytics Biotech Inc. recent moveWeekly Profit Report & Fast Gaining Stock Reports - Newser
Can momentum traders help lift Oncolytics Biotech Inc.July 2025 Outlook & Fast Entry High Yield Tips - Newser
Can Oncolytics Biotech Inc. stock outperform in a bear marketPortfolio Growth Summary & High Win Rate Trade Tips - خودرو بانک
How to use a screener to detect Oncolytics Biotech Inc. breakoutsMarket Growth Summary & Fast Gain Swing Trade Alerts - Newser
Cellectar Biosciences shares fall 1.24% premarket as Oncolytics Biotech Inc. gains FDA approval for breakthrough therapies. - AInvest
How hedge fund analytics apply to Oncolytics Biotech Inc. stock2025 Valuation Update & Advanced Technical Analysis Signals - Newser
What’s the recovery path for long term holders of Oncolytics Biotech Inc.Earnings Performance Report & Stepwise Entry and Exit Trade Signals - Newser
Oncolytics Biotech shares rise 8.70% premarket after providing updated clinical safety data for pelareorep. - AInvest
What technical models suggest about Oncolytics Biotech Inc.’s comebackWeekly Stock Report & Safe Capital Growth Trade Ideas - Newser
What moving averages say about Oncolytics Biotech Inc.Inflation Watch & Target Return Focused Picks - Newser
Using data filters to optimize entry into Oncolytics Biotech Inc.July 2025 Short Interest & Verified High Yield Trade Plans - Newser
Tools to assess Oncolytics Biotech Inc.’s risk profileGap Down & Fast Entry and Exit Trade Plans - Newser
Does Oncolytics Biotech Inc. qualify in momentum factor screening2025 Market Sentiment & Safe Entry Trade Reports - Newser
Using portfolio simulators with Oncolytics Biotech Inc. included2025 Top Decliners & Long-Term Safe Investment Plans - Newser
FDA Fast-Track Cancer Treatments Drive Market Surge as Innovations Accelerate - Baystreet.ca
Oncolytics Biotech Inc. recovery potential after sell off2025 Top Decliners & Fast Gain Swing Trade Alerts - Newser
Trend analysis for Oncolytics Biotech Inc. this weekJuly 2025 Institutional & Technical Buy Zone Confirmation - Newser
Cellectar Biosciences shares fall 1.45% after-hours as Oncolytics Biotech Inc. gains regulatory momentum. - AInvest
Oncolytics Biotech Inc (ONCY) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
0.10%
大文字化:
|
ボリューム (24 時間):